LYPE.DE vs. 2B70.DE
LYPE.DE (Amundi MSCI World Health Care UCITS ETF EUR Acc) and 2B70.DE (iShares Nasdaq US Biotechnology UCITS ETF) are both Health & Biotech Equities funds - LYPE.DE tracks the MSCI World Health Care while 2B70.DE tracks the Nasdaq Biotechnology. Both are passively managed. Over the past 5 years, LYPE.DE returned 5.27%/yr vs 5.68%/yr for 2B70.DE. A 0.72 correlation means they provide meaningful diversification when combined. LYPE.DE charges 0.30%/yr vs 0.35%/yr for 2B70.DE.
Performance
LYPE.DE vs. 2B70.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, LYPE.DE achieves a -2.00% return, which is significantly lower than 2B70.DE's 4.53% return.
LYPE.DE
- 1D
- 2.79%
- 1M
- 3.48%
- YTD
- -2.00%
- 6M
- -1.61%
- 1Y
- 9.70%
- 3Y*
- 2.46%
- 5Y*
- 5.27%
- 10Y*
- 7.45%
2B70.DE
- 1D
- 3.29%
- 1M
- 0.58%
- YTD
- 4.53%
- 6M
- 4.05%
- 1Y
- 39.50%
- 3Y*
- 10.00%
- 5Y*
- 5.68%
- 10Y*
- —
LYPE.DE vs. 2B70.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
LYPE.DE Amundi MSCI World Health Care UCITS ETF EUR Acc | -2.00% | 2.17% | 7.03% | -0.27% | -0.17% | 30.38% | 2.44% | 27.39% | 5.67% | 0.97% |
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF | 4.53% | 18.62% | 4.60% | 2.56% | -6.29% | 7.59% | 14.52% | 30.18% | -7.35% | 2.65% |
Correlation
The correlation between LYPE.DE and 2B70.DE is 0.71, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.71 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.65 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.68 |
Correlation (All Time) Calculated using the full available price history since Nov 24, 2017 | 0.72 |
The correlation between LYPE.DE and 2B70.DE has been stable across timeframes, ranging from 0.65 to 0.72 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
LYPE.DE vs. 2B70.DE — Risk / Return Rank
LYPE.DE
2B70.DE
LYPE.DE vs. 2B70.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Amundi MSCI World Health Care UCITS ETF EUR Acc (LYPE.DE) and iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| LYPE.DE | 2B70.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.36 | ||
| Sortino ratioReturn per unit of downside risk | -1.76 | ||
| Omega ratioGain probability vs. loss probability | 1.13 | 1.34 | -0.21 |
| Calmar ratioReturn relative to maximum drawdown | 0.93 | 6.15 | -5.23 |
| Martin ratioReturn relative to average drawdown | 2.27 | 17.06 | -14.79 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| LYPE.DE | 2B70.DE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.68 | 2.04 | -1.36 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.39 | 0.28 | +0.11 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.51 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.76 | 0.36 | +0.40 |
Drawdowns
LYPE.DE vs. 2B70.DE - Drawdown Comparison
The maximum LYPE.DE drawdown since its inception was -25.95%, smaller than the maximum 2B70.DE drawdown of -30.87%. Use the drawdown chart below to compare losses from any high point for LYPE.DE and 2B70.DE.
Loading charts...
Drawdown Indicators
| LYPE.DE | 2B70.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -25.95% | -30.87% | +4.92% |
Max Drawdown (1Y)Largest decline over 1 year | -10.21% | -6.33% | -3.88% |
Max Drawdown (3Y)Largest decline over 3 years | -21.30% | -29.34% | +8.04% |
Max Drawdown (5Y)Largest decline over 5 years | -21.30% | -30.87% | +9.57% |
Max Drawdown (10Y)Largest decline over 10 years | -25.95% | — | — |
Current DrawdownCurrent decline from peak | -8.75% | -1.26% | -7.49% |
Average DrawdownAverage peak-to-trough decline | -5.06% | -10.01% | +4.95% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.18% | 2.29% | +1.89% |
Volatility
LYPE.DE vs. 2B70.DE - Volatility Comparison
The current volatility for Amundi MSCI World Health Care UCITS ETF EUR Acc (LYPE.DE) is 4.96%, while iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE) has a volatility of 6.65%. This indicates that LYPE.DE experiences smaller price fluctuations and is considered to be less risky than 2B70.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| LYPE.DE | 2B70.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.96% | 6.65% | -1.69% |
Volatility (6M)Calculated over the trailing 6-month period | 9.76% | 14.26% | -4.50% |
Volatility (1Y)Calculated over the trailing 1-year period | 13.82% | 19.09% | -5.27% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 13.41% | 20.34% | -6.93% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 14.64% | 21.76% | -7.12% |
LYPE.DE vs. 2B70.DE - Expense Ratio Comparison
LYPE.DE has a 0.30% expense ratio, which is lower than 2B70.DE's 0.35% expense ratio.
Dividends
LYPE.DE vs. 2B70.DE - Dividend Comparison
Neither LYPE.DE nor 2B70.DE has paid dividends to shareholders.
Frequently Asked Questions
LYPE.DE and 2B70.DE have a correlation of 0.71, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, LYPE.DE is cheaper at 0.30% per year. The better choice depends on whether you care most about return, fees, risk, or income.
LYPE.DE is cheaper with a 0.30% expense ratio, compared with 0.35% for 2B70.DE.
LYPE.DE tracks MSCI World Health Care, while 2B70.DE tracks Nasdaq Biotechnology. They also come from different issuers: Amundi and iShares. Their fees differ too: 0.30% for LYPE.DE and 0.35% for 2B70.DE.
Find the right allocation for LYPE.DE and 2B70.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer